SARS-CoV-2 receptor |Human ACE2-Fc | InvivoGen
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2 - Kidney International
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications - ScienceDirect
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Oral Mucosa Shows High Expression of ACE2 Receptor of 2019-nCoV | PracticeUpdate
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) | Journal of Clinical Pathology
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
View of The regulation of ACE-2 in the heart and lungs | The Southwest Respiratory and Critical Care Chronicles
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
The pivotal role of the angiotensin-II–NF-κB axis in the development of COVID-19 pathophysiology | Hypertension Research
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | SpringerLink
Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic | Hypertension
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
Men's blood contains greater concentrations o | EurekAlert!
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
